Marshall Wace
BNTX icon

Marshall Wace’s BioNTech BNTX Stock Holding History

Marshall Wace’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Sell
2,900
-1,900
-40% -$195K ﹤0.01% 2698
2025
Q4 		$457K Sell
4,800
-100
-2% -$10.1K ﹤0.01% 2273
2025
Q3 		$483K Buy
+4,900
New +$524K ﹤0.01% 2241

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace's BNTX Position: Q1 2026 in Review

Marshall Wace reduced its BioNTech (BNTX) stake by 4.3% in Q1 2026, selling an estimated $1.14M and leaving 249,046 shares worth $22.1M. The position accounts for 0.02% of the portfolio, ranked #672.

Marshall Wace first reported a position in BNTX in Q2 2020 and has held it in 17 quarters since. The position peaked at $57.5M in Q4 2022. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Marshall Wace held 249,046 shares of BioNTech worth $22.1M as of Q1 2026.
  • Marshall Wace sold 11,061 BioNTech shares in Q1 2026, an estimated $1.14M.
  • BioNTech made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #672 holding.
  • Marshall Wace first reported a position in BioNTech in Q2 2020 and has held it in 17 quarters since.
  • Marshall Wace's BioNTech position peaked at $57.5M in Q4 2022.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.